Access cutting-edge systemic lupus erythematosus treatment through this clinical trial at a research site in Gilbert. Study-provided care at no cost to qualified participants.
Access systemic lupus erythematosus specialists in Gilbert at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic lupus erythematosus treatment provided free
The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.
Sponsor: UCB Biopharma SRL
Check if you qualify for this systemic lupus erythematosus clinical trial in Gilbert, AZ
If you're searching for systemic lupus erythematosus treatment options in Gilbert, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gilbert research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic lupus erythematosus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.